I wonder how much of a global market there actually is for leronlimab. We've heard big broad assertions about various countries wanting to purchase all available vials -- but those comments have fallen by the wayside, along with (what I assume to be) the expiration of the Longen LOI. I don't believe any ex-US FDA has conducted clinical trials or approved leronlimab. So, really, what are we talking about here? Seems like a phantom opportunity.